| Primary Malignant Liver Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 188show all (up to 200) |
|---|
| → investigated in trials for | Sorafenibsmall molecule 178 trials (12 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 178 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 144 trials (65 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 144 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 112 trials (63 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 71 trials (22 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 67 trials (44 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 67 trials (47 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 67 trials (21 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 58 trials (28 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 41 trials (20 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 38 trials (14 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 37 trials (15 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 37 trials (28 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 34 trials (15 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 34 trials (13 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 33 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Malignant Liver Neoplasm | 33 | Observed | clinicaltrials | graph → |